Ovira
PrivateLast Round
Seed
Mar 12, 2020
Total Funding Raised
$1.01M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Ovira is a medical technology company that develops non-invasive, wearable devices for menstrual pain relief.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, D2C Brands, E-commerce, Health IoT
Business Model
B2C
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ovira Comparables
Compare Ovira with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iPulse Medical | 93% | |
| Myoovi | 90% | |
| Juno Technologies | 89% | |
Ovira Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 12, 2020 | ||||
| Accelerator | Jul 22, 2019 |
Ovira Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Startmate | Seed, Accelerator |
| Blackbird Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Grew 50% QoQ, from 6 to 9 employees.
- Mar 1, 2026
Monthly visitors increased 58% MoM.
Ovira Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ovira's valuation, stock price, and market status.